A case of nonislet cell tumor hypoglycemia associated with malignant mesothelioma requiring a multifaceted approach for optimal glycemic control

Mariko Ono; Yuki Maeda; Nobuyuki Koyama; Terumasa Nagase; Yoshiya Katsura; Hiroyuki Nakamura; Kazutetsu Aoshiba

doi:10.1002/ccr3.5028

A case of nonislet cell tumor hypoglycemia associated with malignant mesothelioma requiring a multifaceted approach for optimal glycemic control

Clin Case Rep. 2021 Oct 28;9(10):e05028. doi: 10.1002/ccr3.5028. eCollection 2021 Oct.

Authors

Mariko Ono^{1

2}, Yuki Maeda¹, Nobuyuki Koyama³, Terumasa Nagase⁴, Yoshiya Katsura⁴, Hiroyuki Nakamura¹, Kazutetsu Aoshiba¹

Affiliations

¹ Department of Respiratory Medicine Tokyo Medical University Ibaraki Medical Center Ami Japan.
² Department of Respiratory Medicine Tokyo Medical University Tokyo Japan.
³ Department of Clinical Oncology Tokyo Medical University Ibaraki Medical Center Ami Japan.
⁴ Department of Metabolism and Endocrinology Tokyo Medical University Ibaraki Medical Center Ami Japan.

Abstract

Nonislet tumor hypoglycemia (NICTH) is a rare paraneoplastic syndrome characterized by refractory hypoglycemia, which often requires multifaceted therapy. We reported a case of a patient with pleural malignant mesothelioma and developed NICTH, for which chemotherapy, glucocorticoids, and nutrition were given to achieve optimal glycemic control.

Keywords: hypoglycemia; insulin‐like growth factor II; mesothelioma.

Publication types

Case Reports